At the heart of the Oncopole of Toulouse, the CRCT, together with all its partners (institutional, academic, clinical, industrial, charities…), stimulates innovation in terms of research and teaching in the fight against cancer.
The CRCT is a joint Research Unit Inserm & University Toulouse III Paul Sabatier
3 research teams are also labelled by the CNRS
Researchers, clinicians and supports
PhD students and post-doctoral fellows
At a time when e-health is an essential part of modern medicine, virtual slides have become a key element in histopathological diagnosis. Virtual microscopy consists in analyzing high-resolution digitally scanned histology images. The pathologist can observe these...
A small non-coding RNA molecule controls the presence of three key tumor growth regulators of NPM-ALK(+) T lymphoma.
Lymphoma is a blood cancer which develops from a type of white blood cells present in the lymphatic system; the lymphocytes. There are two types of lymphocytes: B lymphocytes and T lymphocytes. This study focuses on a particular type of blood cancer affecting T...
Cytotoxic T cells (CTL) are essential cellular components in the immune response against viruses and cancer. This is why it is essential to better understand the function of these cells and in particular to better understand how these cells manage to kill their target...
Centre de Recherches en Cancérologie de Toulouse
2 avenue Hubert Curien
31037 TOULOUSE CEDEX 1 – FRANCE